Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-25 @ 2:27 AM
NCT ID:
NCT02635334
Eligibility Criteria:
Inclusion Criteria:
* Asthma diagnosed for at least one year;
* Able to swallow small capsules.
Exclusion Criteria:
* Tobacco smoking for more than 10/pack years;
* Previous adverse reaction to montelukast or other leukotriene inhibitor;
* History of hypereosinophilic disorder other than atopic disease;
* Treatment with montelukast within 4 weeks from randomization;
* Asthma exacerbation or treatment with prednisone/other systemic steroid within 4 weeks from randomization.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT02635334
Study Brief:
Protocol Section:
NCT02635334